These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 36333741)

  • 1. A pilot study of evaluation of semi-rigid and flexible catheters for less invasive surfactant administration in preterm infants with respiratory distress syndrome-a randomized controlled trial.
    Auer-Hackenberg L; Brandner J; Hofstätter E; Stroicz P; Hager T; Eichhorn A; Schütz S; Feldner R; Wald M
    BMC Pediatr; 2022 Nov; 22(1):637. PubMed ID: 36333741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
    Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
    Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of less invasive surfactant administration using video laryngoscopy in extremely preterm infants.
    Baczynski M; Deekonda V; Hamilton L; Lindsay B; Ye XY; Jain A
    Pediatr Res; 2023 Mar; 93(4):990-995. PubMed ID: 35854087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant therapy using a bronchofiberscope in respiratory distress syndrome.
    Wasa M; Hasegawa H; Kihara H; Yamada Y; Mizogami M; Kitamura R; Ikeda K
    Pediatr Int; 2023 Jan; 65(1):e15478. PubMed ID: 36656737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation.
    Dargaville PA; Kamlin CO; De Paoli AG; Carlin JB; Orsini F; Soll RF; Davis PG
    BMC Pediatr; 2014 Aug; 14():213. PubMed ID: 25164872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial.
    Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Goss KCW; Tauscher MK; Murthy V; Ali SKM; Clark HW; Soll RF; Johnson S; Cheong JLY; Carlin JB; Davis PG;
    JAMA; 2023 Sep; 330(11):1054-1063. PubMed ID: 37695601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of minimally invasive pulmonary surfactant administration in preterm infants with neonatal respiratory distress syndrome: a multicenter clinical trial].
    Liu HQ; Tong XM; Han TY; Zhang H; Guo M; Zhang XF; Liu XJ; Zhang X; Zhang MT; Liu F; Bao LS; Zheng J; Tian XY; Gao Q; Zhang WX; Duan Y; Sun FF; Guo W; Li L; Xiao M; Liu WL; Jiang R
    Zhonghua Er Ke Za Zhi; 2020 May; 58(5):374-380. PubMed ID: 32392952
    [No Abstract]   [Full Text] [Related]  

  • 8. Less invasive surfactant administration via infant feeding tube versus InSurE method in preterm infants: a randomized control trial.
    Anand R; Nangia S; Kumar G; Mohan MV; Dudeja A
    Sci Rep; 2022 Dec; 12(1):21955. PubMed ID: 36535971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience of less invasive surfactant administration with a 5F infant feeding tube in a tertiary center of low- and middle-income countries.
    Sk MH; Saha B
    Pediatr Int; 2023; 65(1):e15668. PubMed ID: 38009628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial.
    Göpel W; Kribs A; Ziegler A; Laux R; Hoehn T; Wieg C; Siegel J; Avenarius S; von der Wense A; Vochem M; Groneck P; Weller U; Möller J; Härtel C; Haller S; Roth B; Herting E;
    Lancet; 2011 Nov; 378(9803):1627-34. PubMed ID: 21963186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
    Kaniewska U; Gulczyńska E
    Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized Trial of Surfactant Therapy via Laryngeal Mask Airway Versus Brief Tracheal Intubation in Neonates Born Preterm.
    Gallup JA; Ndakor SM; Pezzano C; Pinheiro JMB
    J Pediatr; 2023 Mar; 254():17-24.e2. PubMed ID: 36241051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of less invasive surfactant administration on cerebral oxygenation in preterm infants.
    Hanke K; Rausch TK; Paul P; Hellwig I; Krämer C; Stichtenoth G; Herz A; Wieg C; König IR; Göpel W; Herting E; Härtel C
    Acta Paediatr; 2020 Feb; 109(2):291-299. PubMed ID: 31310677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous positive airway pressure (CPAP) for respiratory distress in preterm infants.
    Ho JJ; Subramaniam P; Davis PG
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD002271. PubMed ID: 33058208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic Oropharyngeal Surfactant for Preterm Newborns at Birth: A Randomized Clinical Trial.
    Murphy MC; Miletin J; Klingenberg C; Guthe HJ; Rigo V; Plavka R; Bohlin K; Barroso Pereira A; Juren T; Alih E; Galligan M; O'Donnell CPF
    JAMA Pediatr; 2024 Feb; 178(2):117-124. PubMed ID: 38079168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung recruitment improves the efficacy of intubation-surfactant-extubation treatment for respiratory distress syndrome in preterm neonates, a randomized controlled trial.
    Yang Y; Yan W; Ruan M; Zhang L; Su J; Deng H; Li M
    BMC Pediatr; 2022 Jan; 22(1):14. PubMed ID: 34980047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive duo positive airway pressure ventilation versus nasal continuous positive airway pressure in preterm infants with respiratory distress syndrome: a randomized controlled trial.
    Malakian A; Aramesh MR; Agahin M; Dehdashtian M
    BMC Pediatr; 2021 Jul; 21(1):301. PubMed ID: 34229655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous distending pressure for respiratory distress in preterm infants.
    Ho JJ; Subramaniam P; Davis PG
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD002271. PubMed ID: 26141572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of combined administration of surfactant and intratracheal budesonide compared to surfactant alone on bronchopulmonary dysplasia (BPD) and mortality rate in preterm infants with respiratory distress syndrome: a single-blind randomized clinical trial.
    Marzban A; Mokhtari S; Tavakkolian P; Mansouri R; Jafari N; Maleki A
    BMC Pediatr; 2024 Apr; 24(1):262. PubMed ID: 38643076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentre, randomised trial of preterm infants receiving caffeine and less invasive surfactant administration compared with caffeine and early continuous positive airway pressure (CaLI trial): study protocol.
    Ines F; Hutson S; Coughlin K; Hopper A; Banerji A; Uy C; Finer N; Rich W; Morales A; Steen J; Katheria AC
    BMJ Open; 2021 Jan; 11(1):e038343. PubMed ID: 33483435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.